Syneos Health Reports Third Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Syneos (SYNH) PT Raised to $116 at Jefferies
November 4, 2021 7:59 AM EDTJefferies analyst David Windley raised the price target on Syneos (NASDAQ: SYNH) to $116.00 (from $105.00) while maintaining a Buy rating.
The analyst commented, "SYNH posted one of its healthier quarters (fewer and smaller puts and takes). Strong 3Q Commercial revenue (+22% org. YoY) and improved... More
Syneos Health, Inc. (SYNH) Tops Q3 EPS by 5c, Offers Guidance
November 3, 2021 6:21 AM EDTSyneos Health, Inc. (NASDAQ: SYNH) reported Q3 EPS of $1.22, $0.05 better than the analyst estimate of $1.17. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.34 billion.
GUIDANCE:
Syneos Health, Inc. sees FY2021 EPS of $4.35-$4.49, versus the... More
